Sodium Acetate (APP Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the Sodium Acetate drug offered from APP Pharmaceuticals, LLC. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | APP Pharmaceuticals, LLC |
| NON-PROPRIETARY NAME: | SODIUM ACETATE |
| SUBSTANCE NAME: | SODIUM ACETATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2000-09-01 |
| END MARKETING DATE: | 0000-00-00 |
Sodium Acetate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Sodium Acetate from APP Pharmaceuticals, LLC |
| LABELER NAME: | APP Pharmaceuticals, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 328(mg/100mL) |
| START MARKETING DATE: | 2000-09-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-032_9d85c8fe-57f4-4400-b8e3-c66a2826d847 |
| PRODUCT NDC: | 63323-032 |
| APPLICATION NUMBER: | |
Other SODIUM ACETATE Pharmaceutical Manufacturers / Labelers:
